4.7 Meeting Abstract

CD19 Expression by IHC Alone Is Not a Predictor of Response to Loncastuximab Tesirine: Results from the LOTIS-2 Clinical Trial and Quantitative Systems Pharmacology Modeling

Journal

BLOOD
Volume 140, Issue -, Pages 9548-9550

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2022-159626

Keywords

-

Categories

Funding

  1. ADC Therapeutics SA

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available